FDA Orange Book

Is there a generic for Ohtuvayre?

Ohtuvayre contains ensifentrine. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

No. The Orange Book lists no active FDA-approved generic (ANDA) for Ohtuvayre (ensifentrine). The Orange Book shows its last listed patent expires June 25, 2044 and its last listed exclusivity ends June 26, 2029.

Run it in Rivvi

Map Ohtuvayre and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Ohtuvayre products in the Orange Book

Ohtuvayre products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
suspension, inhalation3MG/2.5MLMarketed (Rx)None0None

NDA 217389, held by MERCK SHARP AND DOHME LLC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Ohtuvayre patents

Patents listed for Ohtuvayre
PatentExpiresCoversUse codeNDA
9062047August 21, 2031Drug substanceU-3962217389
9956171September 15, 2035Drug productU-3962217389
10945950September 15, 2035Drug productNone217389
12409180February 20, 2043Drug productNone217389
12251384June 25, 2044Drug productNone217389

Ohtuvayre exclusivity

Exclusivity listed for Ohtuvayre
CodeMeaningExpiresNDA
NCENew chemical entityJune 26, 2029217389

Ohtuvayre NDC codes

Questions

Is there a generic for Ohtuvayre?

No. The Orange Book lists no active FDA-approved generic (ANDA) for Ohtuvayre (ensifentrine). The Orange Book shows its last listed patent expires June 25, 2044 and its last listed exclusivity ends June 26, 2029.

What is the generic name for Ohtuvayre?

The active ingredient in Ohtuvayre is ensifentrine, per the FDA Orange Book.

When does the Ohtuvayre patent expire?

The last patent listed for Ohtuvayre in the Orange Book expires June 25, 2044. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Ohtuvayre and Ensifentrine

Try it on your own data today.

Free to start. Most teams are using it the same day.